An unusual BRCA mutation distribution in a high risk cancer genetics clinic

Anna C. Nelson-Moseke, Joanne M. Jeter, Haiyan Cui, Denise J. Roe, Setsuko K. Chambers, Christina M. Laukaitis

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The Database of Individuals at High Risk for Breast, Ovarian, or Other Hereditary Cancers at the Arizona Cancer Center in Tucson, Arizona assesses cancer risk factors and outcomes in patients with a family history of cancer or a known genetic mutation. We analyzed the subset of clinic probands who carry deleterious BRCA gene mutations to identify factors that could explain why mutations in BRCA2 outnumber those in BRCA1. Medical, family, social, ethnic and genetic mutation histories were collected from consenting patients' electronic medical records. Differences between BRCA1 and BRCA2 probands from this database were analyzed for statistical significance and compared to published analyses. A significantly higher proportion of our clinic probands carry mutations in BRCA2 than BRCA1, compared with previous reports of mutation prevalence. This also holds true for the Hispanic sub-group. Probands with BRCA2 mutations were significantly more likely than their BRCA1 counterparts to present to the high risk clinic without a diagnosis of cancer. Other differences between the groups were not significant. Six previously unreported BRCA2 mutations appear in our clinic population. The increased proportion of probands carrying deleterious BRCA2 mutations is likely multifactorial, but may reflect aspects of Southern Arizona's unique ethnic heritage.

Original languageEnglish (US)
Pages (from-to)83-87
Number of pages5
JournalFamilial Cancer
Volume12
Issue number1
DOIs
StatePublished - Mar 2013

Keywords

  • BRCA1
  • BRCA2
  • Breast cancer
  • Hereditary cancer syndromes
  • Ovarian cancer

ASJC Scopus subject areas

  • Genetics
  • Oncology
  • Genetics(clinical)
  • Cancer Research

Fingerprint

Dive into the research topics of 'An unusual BRCA mutation distribution in a high risk cancer genetics clinic'. Together they form a unique fingerprint.

Cite this